Northern Trust’s Telomir Pharmaceuticals TELO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$52.3K Sell
41,844
-112,228
-73% -$140K ﹤0.01% 4225
2025
Q1
$498K Buy
154,072
+2,444
+2% +$7.89K ﹤0.01% 3581
2024
Q4
$625K Buy
151,628
+102,948
+211% +$424K ﹤0.01% 3577
2024
Q3
$313K Buy
+48,680
New +$313K ﹤0.01% 3720